Showing results (101-110 of 403) with videos related to
Sort By:
Pageof 41
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2005
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group studyRani E George, Wendy B London, Susan L Cohn, et al.Pediatric Blood & Cancer|May 4, 2011
Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing programChristopher L Morton, John M Maris, Stephen T Keir, et al.Neuro-Oncology|September 11, 2019
Immunotherapy for pediatric brain tumors: past and presentJessica B Foster, Peter J Madsen, Meenakshi Hegde, et al.Scientific Reports|October 4, 2024
Comparison of human pluripotent stem cell differentiation protocols to generate neuroblastoma tumorsBo Cheng, Wanqi Fang, Steven Pastor, et al.Molecular Cancer Therapeutics|November 7, 2025
Defining the functional role and potential as an immunotherapeutic target of ALCAM in neuroblastomaJarrett Lindsay, Jonathan Gaither, David Groff, et al.Pediatric Blood & Cancer|June 2, 2011
Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, John M Maris, et al.Pediatric Blood & Cancer|July 9, 2015
Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, John M Maris, et al.Pediatric Blood & Cancer|January 31, 2006
Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastomaJulia A Messina, Su-Chun Cheng, Benjamin L Franc, et al.Journal of the National Cancer Institute|March 18, 2014
Rare variants in TP53 and susceptibility to neuroblastomaSharon J Diskin, Mario Capasso, Maura Diamond, et al.Cancer Research|October 15, 2014
Common genetic variants in NEFL influence gene expression and neuroblastoma riskMario Capasso, Sharon Diskin, Flora Cimmino, et al.Pageof 41